# Pixelgen Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pixelgen-technologies

- Industry: Biotechnology
- Headquarters: Stockholm, Sweden
- Website: www.pixelgen.com
- Total disclosed funding: $29M
- Latest round: Series B (Aug 20, 2026)
- Investors on record: 4

## About

Based in Sweden and founded in 2020 by its CEO, Simon Fredriksson, Chief Data Analytics Officer, Álvaro Martínez Barrio, and Chief Technology Officer, Filip Karlsson, Pixelgen Technologies AB, operates as a spatial proteomics company that offers molecular pixelation solutions. In August 2026, Pixelgen Technologies AB raised SEK 150 million in series B funding led by Flat Capital, with participation from Industrifonden and Navigare Ventures. The company offers biotechnology solutions that include Molecular Pixelation, a DNA-based visualization technology for analyzing cell surface proteins. The company also provides spatial proteomics, including reagents and data analysis tools for improving medicines and diagnostics services. The company plans to utilize the August 2026 funding to commercialize its Proxiome Kit globally, expand in key markets, and grow its team and product portfolio.

## Funding rounds

- Series B, Aug 20, 2026, $16M — Industrifonden, Flat Capital, Navigare Ventures
- Series A, Oct 9, 2023, $7.3M — Industrifonden, Navigare Ventures
- Seed, Dec 7, 2022, $6M — Colibri Group, LLC, Navigare Ventures

## Investors

- Colibri Group, LLC — Seed
- Navigare Ventures (https://capitalatlas.ai/funds/navigare-ventures) — Seed, Series A, Series B
- Industrifonden (https://capitalatlas.ai/funds/industrifonden) — Series A, Series B
- Flat Capital (https://capitalatlas.ai/funds/flat-capital) — Series B